View Author
Schellekens, H.
(Huub Schellekens)
interferon virus study patient effect activity infection preparation result health hepatitis regulation marrow inhibition vaccinia monkey interferon preparations table growth group vaccinia virus hbsag mouse control administration fibroblast number chapter method drug regulation dnap activity culture antipsychotic serum production death fibroblast interferon treatment injection interferon administration reference colony tqt study concentration lesion scenario laboratory bone marrow rhesus monkeys tqt studies transplant recipients journal antipsychotic drugs leucocyte health gains rat cells system development challenge ich e 14 virology l 929 cells analysis rhesu interferon group market ecg monitoring herpe transplantation prolongation cost-effectiveness protection health effects recipient university level assay disease hbeag 2 patients
5 Most Recent Publications
|
The cost-effectiveness of periodic safety update reports for biologicals in Europe
(Article)
Bouvy, J.C. Ebbers, H.C. Schellekens, H. Koopmanschap, M.A. |
2013-05-01
|
|
Value for money of drug regulation
(Article)
Bouvy, J.C. Koopmanschap, M.A. Schellekens, H. |
2012-06-01
|
|
The cost-effectiveness of drug regulation: The example of thorough QT/QTc studies
(Article)
Bouvy, J.C. Koopmanschap, M.A. Shah, R.R. Schellekens, H. |
2012-02-01
|
|
Interferons, properties and applications
(Doctoral Thesis)
Schellekens, H. Weimar, W. |
1980-05-14
|
|
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro
(Article)
Hull, E. van 't Löwenberg, B. Vries, M. de Schellekens, H. |
1978-01-01
|
